H. pylori Treatment for Uninsured Patients with Penicillin Allergy

First-Line Treatment Option

The American Gastroenterological Association recommends bismuth quadruple therapy for 14 days as the most cost-effective first-line treatment for H. pylori infection in patients with penicillin allergy 1, 2
Bismuth subsalicylate 262 mg (2 tablets) four times daily is recommended as part of the bismuth quadruple therapy regimen 2
Metronidazole 500 mg three times daily is recommended as part of the bismuth quadruple therapy regimen 2
Tetracycline 500 mg four times daily is recommended as part of the bismuth quadruple therapy regimen 2
PPI (standard dose) twice daily for 14 days is recommended as part of the bismuth quadruple therapy regimen, with standard PPI doses including omeprazole 20 mg, lansoprazole 30 mg, pantoprazole 40 mg, and rabeprazole 20 mg 1, 2

Generic versions of all medications should be used to reduce costs 2
Walmart, Costco, and other large retailers often offer $4 generic medication programs that include tetracycline and metronidazole 2
Patient assistance programs may be available for PPIs 2
Bismuth subsalicylate is available over-the-counter as Pepto-Bismol, which is often less expensive than prescription bismuth preparations 2

Levofloxacin 500 mg once daily is recommended as part of the levofloxacin-based triple therapy regimen 2
Clarithromycin 500 mg twice daily is recommended as part of the levofloxacin-based triple therapy regimen 3
PPI (standard dose) twice daily for 10-14 days is recommended as part of the levofloxacin-based triple therapy regimen 3, 2

PPI should be taken 30 minutes before eating on an empty stomach 2
Avoid concomitant use of other antacids during treatment 2
Metronidazole should be taken with food to minimize gastrointestinal side effects 4
Patients should avoid alcohol while taking metronidazole due to disulfiram-like reactions 4
14-day treatment duration is preferred over shorter courses for better eradication rates 2, 4
Complete adherence to the full treatment course is essential for successful eradication 2
If first-line therapy fails, consider penicillin allergy testing as many patients labeled as allergic are not truly allergic 2, 5
Delabeling of penicillin allergy would allow use of amoxicillin-containing regimens, which have higher success rates 4

Clarithromycin resistance is increasing globally, making clarithromycin-based triple therapy less effective as a first-line option 1
Levofloxacin resistance is also increasing, potentially limiting its effectiveness in some regions 1
Metronidazole resistance may be present but can often be overcome with higher doses and longer treatment duration 4
If two treatment attempts fail, H. pylori susceptibility testing should be considered to guide further therapy 2, 6